Literature DB >> 11863357

Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.

Thomas D Barber1, Melisa C Barber, Oana Tomescu, Frederic G Barr, Steve Ruben, Thomas B Friedman.   

Abstract

PAX3 is a transcription factor important for neural, muscle, and facial development in vertebrates. To identify genes regulated by PAX3, we used a cyclic amplification and selection of targets (CASTing) strategy to isolate cis-regulatory elements bound by PAX3. CASTing libraries were constructed with mouse DNA fragments bound by mouse PAX3, and human genomic DNA fragments bound by human PAX3 and the fusion protein PAX3-FKHR. Approximately 1000 clones were sequenced from each of these three libraries. Numerous putative targets of PAX3 and PAX3-FKHR were identified and six genes, Itm2A, Fath, FLT1, TGFA, BVES, and EN2, were examined closely. The genomic DNA fragments near these genes contain PAX3 binding sites and confer PAX3-dependent regulation. The expression levels of these genes correlate with the PAX3 expression levels in mouse embryos or with PAX3-FKHR expression levels in rhabdomyosarcoma cell lines, and indicate they may be part of the PAX3 regulatory circuitry during embryogenesis and tumor formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863357     DOI: 10.1006/geno.2002.6703

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  29 in total

Review 1.  Bves, a member of the Popeye domain-containing gene family.

Authors:  Megan E Osler; Travis K Smith; David M Bader
Journal:  Dev Dyn       Date:  2006-03       Impact factor: 3.780

2.  Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.

Authors:  Teresa San-Miguel; Sandra Pinto; Lara Navarro; Robert C Callaghan; Carlos Monteagudo; Concha López-Ginés; Miguel Cerdá-Nicolás; Rosario Gil-Benso
Journal:  Pathol Oncol Res       Date:  2015-06-03       Impact factor: 3.201

3.  Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sandeep Sreevalsan; Satya Pathi; Kyounghyun Kim; Candy Chen; Lisa Crose; Corinne Linardic; Stephen Safe
Journal:  Int J Cancer       Date:  2012-08-03       Impact factor: 7.396

Review 4.  Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.

Authors:  Julia Glade Bender; Darrell J Yamashiro; Elizabeth Fox
Journal:  Oncologist       Date:  2011-10-31

5.  Isolation, sequence identification and tissue expression distribution of three novel porcine genes--RAB14, S35A3 and ITM2A.

Authors:  G Y Liu; C R Ge; X Zhang; S Z Gao
Journal:  Mol Biol Rep       Date:  2007-03-23       Impact factor: 2.316

Review 6.  PAX3-FOXO1 fusion gene in rhabdomyosarcoma.

Authors:  Corinne M Linardic
Journal:  Cancer Lett       Date:  2008-05-23       Impact factor: 8.679

7.  The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma.

Authors:  Narendra Bharathy; Noah E Berlow; Eric Wang; Jinu Abraham; Teagan P Settelmeyer; Jody E Hooper; Matthew N Svalina; Yoshihiro Ishikawa; Keith Zientek; Zia Bajwa; Martin W Goros; Brian S Hernandez; Johannes E Wolff; Michelle A Rudek; Linping Xu; Nicole M Anders; Ranadip Pal; Alexandria P Harrold; Angela M Davies; Arya Ashok; Darnell Bushby; Maria Mancini; Christopher Noakes; Neal C Goodwin; Peter Ordentlich; James Keck; Douglas S Hawkins; Erin R Rudzinski; Bishwanath Chatterjee; Hans Peter Bächinger; Frederic G Barr; Jennifer Liddle; Benjamin A Garcia; Atiya Mansoor; Theodore J Perkins; Christopher R Vakoc; Joel E Michalek; Charles Keller
Journal:  Sci Signal       Date:  2018-11-20       Impact factor: 8.192

8.  Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling.

Authors:  Wessen Maruwge; Pádraig D'Arcy; Annika Folin; Slavica Brnjic; Johan Wejde; Anthony Davis; Fredrik Erlandsson; Jonas Bergh; Bertha Brodin
Journal:  Onco Targets Ther       Date:  2008-11-01       Impact factor: 4.147

Review 9.  Molecular genetics of pediatric soft tissue tumors: clinical application.

Authors:  Chung-Che Chang; Vinod B Shidham
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

Review 10.  Clinical relevance of molecular genetics to paediatric sarcomas.

Authors:  Olga Slater; Janet Shipley
Journal:  J Clin Pathol       Date:  2007-04-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.